Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference

Core Points - Nutriband Inc. will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on October 8, 2025, at 15:00 Eastern Standard Time, featuring a Q&A session with the audience [1] - The presentation will be available for viewing via a video webcast on Channelchek and will be archived for 90 days [3] - Nutriband is focused on developing transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch utilizing AVERSA™ technology [5] Company Overview - Nutriband's AVERSA™ technology incorporates aversive agents into transdermal patches to prevent drug abuse, ensuring safety while maintaining accessibility for patients in need [4] - The company holds a broad intellectual property portfolio with patents granted in multiple countries, including the United States, Europe, and China [4] - Nutriband's primary engagement is in the development of transdermal products aimed at reducing the potential for drug misuse and accidental exposure [5] Event Details - Attendees can register for the virtual conference at no cost, and qualified investors can schedule one-on-one meetings with company management [2] - The event is organized by Noble Capital Markets, a full-service investment bank with a strong research team and a history of raising billions for companies [7] - Channelchek, launched by Noble in 2018, provides free access to institutional-quality research for emerging growth companies [8]